Prestige Consumer Healthcare Inc. reported third‑quarter fiscal 2026 revenue of $283.4 million, a 0.48% beat over the consensus estimate of $282.09 million and a 2.4% decline from the $290.3 million earned in the same period a year earlier. The modest upside was driven by stronger demand in the eye‑care segment, bolstered by the recent Pillar5 acquisition, while supply constraints on its Clear Eyes product line limited growth in the consumer‑direct channel.
The company posted net income of $46.7 million and earnings per share of $0.97. Non‑GAAP net income rose to $54.9 million and non‑GAAP EPS reached $1.14, missing the consensus estimate of $1.16 by 1.3%. The miss was largely attributable to a $10 million write‑off of a supplier facility and higher cost of goods sold stemming from disrupted supply chains.
Gross margin for the quarter was 55.5%, up 50 basis points from the prior year. The improvement reflects pricing power in the newly acquired Pillar5 portfolio and disciplined cost management in manufacturing, offsetting the impact of higher raw‑material costs.
Management revised its fiscal‑2026 outlook to total revenue of $1.1 billion and free cash flow of $245 million or more, a downward adjustment from the previous guidance of $1.119 billion. The guidance cut signals caution amid consumer volatility and ongoing supply‑chain headwinds, while the company remains confident in maintaining profitability.
CEO Ron Lombardi said the quarter “exceeded our revenue outlook and delivered solid profitability, reflecting the benefits of our diverse business model and strong financial profile.” CFO Chris Sacco highlighted the company’s robust free‑cash‑flow generation and the optionality it provides for future investments.
Investors reacted negatively to the earnings release, citing the EPS miss and the lower‑than‑expected revenue guidance as primary concerns. The market’s focus on these metrics underscores the importance of earnings precision and forward guidance in shaping investor sentiment.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.